Cbdmd's clinical study supports improved mobility in dogs

Results from the canine clinical study suggest that cbdmd's proprietary blend promotes mobility in dogs charlotte, north carolina--(newsfile corp. - april 18, 2023) - cbdmd®, inc. (nyse american: ycbd) (nyse american: ycbdpa), one of the nation's leading, highly trusted and widely recognized cbd companies, today announces the results from its canine clinical study conducted at colorado state university. the clinical study explored the benefits of our core broad spectrum hemp extract in dogs, and the data suggests that daily consumption of the product positively impacted dogs' mobility.
YCBD Ratings Summary
YCBD Quant Ranking